In-Depth Analysis of the Cerebrospinal Fluid Proteome and Biomarker Discovery: Abundant Protein Depletion Sample Pretreatment Method

  • Silvina A. Fratantoni
  • Connie R. JimenezEmail author
Part of the Neuromethods book series (NM, volume 57)


Cerebrospinal fluid (CSF) contains peptides and proteins important for brain physiology and potentially also relevant to brain pathology. Therefore, CSF provides an attractive source for biomarker discovery in brain and neurological diseases. CSF proteomics provides an analytical challenge as ∼80% of proteins originate from serum, and removal of these major proteins is necessary to study brain-derived proteins that are present at low concentrations. In this book chapter, we describe a CSF sample pretreatment method to allow for in-depth and comparative analysis of the CSF proteome. To this end, we provide a protocol for batch-mode abundant protein depletion using the multiple affinity removal system MARS cartridge (Agilent) as well as for subsequent protein concentration using ultrafiltration with a 3 kDa molecular weight cutoff (MWCO) spin filter (Millipore). In addition, our experience with this depletion method coupled to 1D page/LC-MS/MS as well as other depletion and protein fractionation methods for CSF analysis is discussed.

Key words

CSF Affinity depletion IgY spin filter MARS cartridge MWCO filter Sensitivity Reproducibility Biomarker discovery 



SF is supported by the EU FP6 cNeuPRO project.


  1. 1.
    Zhang, J., Goodlett, D.R. and Montine, T.J. (2005) Proteomic biomarker discovery in cerebrospinal fluid for neurodegenerative diseases. J Alzheimers Dis. 8, 377–386.PubMedGoogle Scholar
  2. 2.
    Westman-Brinkmalm, A., Ruetschi, U., Portelius, E., Andreasson, U., Brinkmalm, G., Karlsson, G., et al. (2009) Proteomics/peptidomics tools to find CSF biomarkers for ­neurodegenerative diseases. Front Biosci. 14, 1793–1806.PubMedCrossRefGoogle Scholar
  3. 3.
    Jiménez, C.R., Koel-Simmelink, M., Pham, T.V., Van der Voort, L. and Teunissen, C.E. (2007) Endogeneous peptide profiling of cerebrospinal fluid by MALDI-TOF mass spectrometry: Optimization of magnetic bead-based peptide capture and analysis of preanalytical variables. Proteomics Clin. Appl. 1, 1385–1392.PubMedCrossRefGoogle Scholar
  4. 4.
    Zolotarjova, N., Mrozinski, P., Chen, H. and Martosella, J. (2007) Combination of affinity depletion of abundant proteins and reversed-phase fractionation in proteomic analysis of human plasma/serum. J Chromatogr. A. 1189, 332–338.PubMedGoogle Scholar
  5. 5.
    Ogata, Y., Charlesworth, M.C. and Muddiman, D.C. (2005) Evaluation of ­protein depletion methods for the analysis of total-, phospho- and glycoproteins in lumbar cerebrospinal fluid. J Proteome Res. 4, 837–845.PubMedCrossRefGoogle Scholar
  6. 6.
    Shores, K.S. and Knapp, D.R. (2007) Assessment approach for evaluating high abundance protein depletion methods for cerebrospinal fluid (CSF) proteomic analysis. J Proteome Res. 6, 3739–3751.PubMedCrossRefGoogle Scholar
  7. 7.
    Fratantoni, S.A., Piersma, S.R. and Jimenez, C.R. (2010) Comparison of the performance of two affinity depletion spin filters for quantitative proteomics of cerebrospinal fluid: Evaluation of sensitivity and reproducibility of CSF analysis using GeLC-MS/MS and spectral counting. Proteomics Clin. Appl. 4, 613–617.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  1. 1.OncoProteomics Laboratory, Department of Medical OncologyVU University Medical Center-Cancer Center AmsterdamAmsterdamThe Netherlands

Personalised recommendations